US-based ALung Technologies has obtained CE mark approval for its new Hemolung XG4 Cartridge and Catheter kits.
The new devices have been designed for use under Hemolung Respiratory Assist System to provide respiratory dialysis, a minimally invasive extracorporeal CO2 removal therapy.
ALung Technologies chairman and CEO Peter DeComo said: "These new kits were developed at the request of our growing user base who identified pre-connected tubing as its most desired feature.
"This update is a major step forward in making Hemolung therapy even easier to implement, and we are pleased to make it available to our customers."
Hemolung XG4 Cartridge Kit features a fully pre-connected circuit that accelerates the initiation of Hemolung therapy by reducing several steps from the setup process.
The company has packed the new kits in sterile plastic trays, which helps in easy handling at the bedside.
In addition, all insertion accessories have been packaged with the catheter in one tray in the Hemolung Catheter Kit, in a bid to improve its usage under sterile conditions.
ALung will exhibit the Hemolung XG4 kits at the sixth International Congress on ECMO in Paris, France, which will be held from 25 to 26 June.
Image: The new Hemolung XG4 Cartridge and Catheter Kits further simplify initiation of respiratory dialysis. Photo: courtesy of ALung Technologies, Inc.